logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Diabetes Therapy cover

Diabetes Therapy

IF2.6
Papers261
Citations4102
Journal Papers 235
Publication Date
delete
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus
deleteDiabetes Therapy
IF2.6
delete2026-09-28
delete0
deleteOAAI
deleteTheodoros Panou; Evanthia Gouveri; Djordje S. Popovic; Nikolaos Papanas
deleteShare
deleteSave
Combined Semaglutide and Sodium–Glucose Cotransporter-2 Inhibitor Use and Metabolic Outcomes in Chinese Adults With Diabetes: Post Hoc Analysis
deleteDiabetes Therapy
IF2.6
delete2026-09-28
delete0
deleteOAAI
deleteShanshan Wang; Bixuan Dong; Zewei Shen
deleteShare
deleteSave
Impact of Education in Disease Management Program for Patients with Diabetes Mellitus on All-Cause Mortality: A Propensity Score-Matched Cohort Study
deleteDiabetes Therapy
IF2.6
delete2026-09-24
delete0
deleteOAAI
deleteMartin Selvek; Beáta Saal; Roman Mužik; Ivan Tkáč
deleteShare
deleteSave
Comparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies Among Adults with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
deleteDiabetes Therapy
IF2.6
delete2026-09-17
delete0
deleteOAAI
deleteXi Tan; Yuanjie Liang; Caichen Zhong; Lin Xie; Mico Guevarra; Caroline Swift; Adam de Havenon
deleteShare
deleteSave
Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial
deleteDiabetes Therapy
IF2.6
delete2026-09-17
delete0
deleteOAAI
deleteKatie D. Stewart; Louis S. Matza; Chanadda Chinthammit; Imre Pavo; Amy K. Bartee; Kristina S. Boye
deleteShare
deleteSave
Study Protocol for the TIGHTEN Study Comparing the Effects of Tofogliflozin and Glimepiride on Skeletal Muscle Mass in Patients with Type 2 Diabetes without Obesity: A Prospective, Multicenter, Open-Label, Randomized, Parallel Group Trial in Japan
deleteDiabetes Therapy
IF2.6
delete2026-09-15
delete0
deleteOAAI
deleteYasutaka Takeda; Tsubasa Ozawa; Maki Ikoma; Keiji Shimada; Reina Saito; Atsushi Nakagawa; Toshitaka Sawamura; Naoki Kumashiro
deleteShare
deleteSave
Performance of the i-SENS CareSens Air CGM System in Compliance with the European CGM (eCGM) Clinical Performance Criteria: A Pooled Analysis
deleteDiabetes Therapy
IF2.6
delete2026-09-15
delete0
deleteOAAI
deleteNina Jendrike; Kyung-Soo Kim; Seung-Hwan Lee; Won Sang Yoo; Cheol-Young Park; Sükrü Öter; Lorena Morent; Manuel Eichenlaub; Guido Freckmann
deleteShare
deleteSave
Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study
deleteDiabetes Therapy
IF2.6
delete2026-09-08
delete0
deleteOAAI
deleteHironori Waki; Hideaki Kagitani; Satoshi Osaga; Mariko Inoue; Daisuke Yabe
deleteShare
deleteSave
Correction to: Continuous Lumbar Sympathetic Blockade Enhances the Effect of Lumbar Sympatholysis on Refractory Diabetic Neuropathy: A Randomized Controlled Trial
deleteDiabetes Therapy
IF2.6
delete2026-09-04
delete0
deleteOAAI
deleteHaiyan Sun; Mingwei He; Jinlei Pang; Xiangfei Guo; Yansong Huo; Jun Ma
deleteShare
deleteSave
Effect of Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists on Myocardial Infarction and Stroke in Type 2 Diabetes: A Systematic Review and Meta-Analysis
deleteDiabetes Therapy
IF2.6
delete2026-09-01
delete0
deleteOAAI
deleteRoya Ghafoury; Mobin Naghshbandi; Mojtaba Malek; Sanjay Kalra; Faramarz Ismail-Beigi; Mohammad E. Khamseh
deleteShare
deleteSave
The Role of SGLT2 Inhibitors in the Prevention of Type 2 Diabetes: A Narrative Review of Current Evidence
deleteDiabetes Therapy
IF2.6
delete2026-08-29
delete0
deleteOAAI
deleteAnna C. Owczarczyk-Durma; Monika Blicharska; Leszek Czupryniak
deleteShare
deleteSave
Targeting Habitual Fast Eating as a Modifiable Risk Factor for Type 2 Diabetes: A Propensity Score-Matched Analysis
deleteDiabetes Therapy
IF2.6
delete2026-08-26
delete0
deleteOAAI
deleteEmmanuele Dutra da silva Andrade; Yuichiro Obana; Mika Suzuki; Shigenori Nagai; Tetsuya Hosooka; Yuki Shimba; Toshio Hosaka
deleteShare
deleteSave
The Complex Interplay Between Dyslipidemic Subjects Living with Type 2 Diabetes and Metabolic Syndrome and Statin Treatment: A Reflection on Adherence and Persistence in the Real World
deleteDiabetes Therapy
IF2.6
delete2026-08-25
delete0
deleteOAAI
deleteFelice Strollo; Giuseppina Guarino; Ersilia Satta; Giuseppe Caccavale; Maria Chiarello; Maria Carla Sibilio; Carmine Romano; Roberta Di Martino; Rosina De Luca; Raffaele Marfella; Sandro Gentile
deleteShare
deleteSave
Antidiabetic Treatment Intensity and Diabetic Peripheral Neuropathy in a County-Level Metabolic Management Center: A Real-World Cross-Sectional Study
deleteDiabetes Therapy
IF2.6
delete2026-08-25
delete0
deleteOAAI
deleteW. J. Chen; Jie Zhou; Jue Peng
deleteShare
deleteSave
Continuous Glucose Monitoring in Gestational Diabetes Mellitus: Evidence, Clinical Benefits and Remaining Challenges
deleteDiabetes Therapy
IF2.6
delete2026-08-22
delete0
deleteOAAI
deleteDorota Bomba-Opoń; Katarzyna Cypryk; Krzysztof Czajkowski; Ewa Wender-Ożegowska; Dorota Zozulińska-Ziółkiewicz
deleteShare
deleteSave
Considering Deintensification and Deprescribing with Higher HbA1c Targets in Vulnerable Older Adults with Type 2 Diabetes: A Retrospective Database Study
deleteDiabetes Therapy
IF2.6
delete2026-08-18
delete0
deleteOAAI
deleteRuriko Koto; Shiori Yoshida; Akihiro Nakajima; Ken Sugimoto
deleteShare
deleteSave
Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)
deleteDiabetes Therapy
IF2.6
delete2026-08-14
delete0
deleteOAAI
deleteLinong Ji; Liming Chen; Zhifeng Cheng; Yibing Lu; Yan Yang; Fangming Fu; Yinan Zhu; Liying Jin; Isabel M. Kloer
deleteShare
deleteSave
Healthcare Cost Impacts of Telehealth-Delivered Nutrition Therapy among US Adults with Type 2 Diabetes or Obesity: A Matched Difference-in-Differences Analysis
deleteDiabetes Therapy
IF2.6
delete2026-08-11
delete0
deleteOAAI
deletePriya V. Shanmugam; Rebecca N. Adams; Shaminie J. Athinarayanan; Adam J. Wolfberg; Jeromie M. Ballreich
deleteShare
deleteSave
Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes
deleteDiabetes Therapy
IF2.6
delete2026-08-10
delete0
deleteOAAI
deleteSean M. Oser; Chad Crystal; Kazanna C. Hames; Xuan Li; Peggy Gao; Margaret A. Crawford; Christian Hicks; Matthew Gerber; Thibault Gautier; Patricio Colmegna; Lei Yang; Harsimran Singh; Matthew L. Johnson; Stayce E. Beck
deleteShare
deleteSave
Type 2 Diabetes Mellitus and Chronic Venous Disease of the Lower Extremities: A Narrative Review
deleteDiabetes Therapy
IF2.6
delete2026-08-10
delete0
deleteOAAI
deleteJuan Rosas Saucedo; David González Villordo; Hugo Laparra Escareño; Norma Areli Rivera García; Luis Fernando Flota Cervera; Isaac Sinay; Juan Rosas Guzmán; Daniel Zingg
deleteShare
deleteSave